# Nonparametric Effect Sizes Implementation

## Overview
This document describes the standardized implementation of Cliff's Delta and Hodges-Lehmann Shift across ClinicoPath modules.

## Modules Enhanced

### ✅ Priority 1: Core Statistical Modules

#### 1. `enhancednonparametric.b.R` - COMPLETED
- **Features:** Both Cliff's Delta and Hodges-Lehmann Shift
- **Implementation:** Full clinical interpretations with lymph node adequacy examples
- **UI Integration:** Effect sizes table with interpretations
- **Clinical Focus:** Method A vs Method B comparisons with clinical adequacy implications

#### 2. `jjridges.b.R` - COMPLETED  
- **Features:** Both measures added to effect size options
- **Implementation:** Integrated with existing statistical testing framework
- **UI Integration:** Added to analysis specification (.a.yaml) as nonparametric options
- **Clinical Focus:** Distribution comparison with skewed data handling

#### 3. `nonparametric.b.R` - COMPLETED
- **Features:** Complete effect size calculation framework
- **Implementation:** Added missing `.calculateEffectSizes()` function
- **UI Integration:** Effect sizes table with generic interpretations
- **Clinical Focus:** Basic two-group comparisons

### ✅ Priority 2: Specialized Clinical Modules

#### 4. `biomarkerresponse.b.R` - COMPLETED
- **Features:** Both measures integrated with Wilcoxon testing
- **Implementation:** Biomarker-specific clinical interpretations
- **UI Integration:** Enhanced statistical results with effect size reporting
- **Clinical Focus:** Biomarker-response associations with clinical significance assessment

## Standardized Functions

### Cliff's Delta Calculation
```r
.calculateCliffsDelta = function(x, y) {
    # Cliff's Delta: proportion of pairs where x > y minus proportion where x < y
    n1 <- length(x)
    n2 <- length(y)
    
    greater <- 0
    less <- 0
    
    for (xi in x) {
        for (yj in y) {
            if (xi > yj) greater <- greater + 1
            else if (xi < yj) less <- less + 1
        }
    }
    
    delta <- (greater - less) / (n1 * n2)
    return(delta)
}
```

### Hodges-Lehmann Shift Calculation
```r
.calculateHodgesLehmann = function(x, y) {
    # Hodges-Lehmann shift: median of all pairwise differences (x - y)
    differences <- c()
    
    for (xi in x) {
        for (yj in y) {
            differences <- c(differences, xi - yj)
        }
    }
    
    return(median(differences))
}
```

## Clinical Interpretation Guidelines

### Cliff's Delta (δ) Thresholds
- **|δ| < 0.147:** Negligible effect
- **|δ| 0.147-0.33:** Small effect  
- **|δ| 0.33-0.474:** Medium effect
- **|δ| > 0.474:** Large effect

**Clinical Translation:** Probability = (δ + 1)/2 × 100%
- δ = 0.4 means 70% chance Group 1 > Group 2

### Hodges-Lehmann Shift Thresholds
- **Generic Applications:**
  - < 0.5 units: Minimal difference
  - 0.5-2 units: Small difference  
  - 2-5 units: Moderate difference
  - > 5 units: Large difference

- **Lymph Node Adequacy Applications:**
  - < 3 LN: Unlikely to affect adequacy assessment
  - 3-6 LN: May improve adequacy rates  
  - > 6 LN: Substantial improvement

## Research Applications

### Perfect for:
1. **Skewed Clinical Data** (lymph node counts, biomarker levels)
2. **Adequacy Assessments** (≥12 LN threshold analysis)
3. **Method Comparisons** (surgical techniques, diagnostic methods)
4. **Biomarker Research** (treatment response associations)

### Advantages over Parametric Effect Sizes:
1. **Robust to outliers** and non-normal distributions
2. **Direct clinical interpretation** (probability and magnitude)
3. **No distributional assumptions** required
4. **Meaningful for small samples** and discrete data

## Implementation Notes

### For Turkish Researcher's Lymph Node Analysis:
- Use `enhancednonparametric.b.R` module
- Select Mann-Whitney U test with nonparametric testing
- Results include both Cliff's δ and Hodges-Lehmann shift
- Clinical interpretations automatically generated
- Adequacy implications (≥12 LN) highlighted

### Module-Specific Features:
- **enhancednonparametric:** Most comprehensive clinical guidance
- **jjridges:** Integrated with distribution visualization
- **biomarkerresponse:** Biomarker-specific interpretations
- **nonparametric:** Basic implementation for general use

## Future Enhancements

### Potential Additions:
1. **Confidence intervals** for both effect sizes
2. **Bootstrap resampling** for effect size stability
3. **Multi-group extensions** for Kruskal-Wallis testing
4. **Visualization components** showing effect size magnitude

### Standardization:
All implementations follow consistent:
- Function naming conventions
- Clinical interpretation thresholds  
- Generic vs. specific clinical guidance
- Error handling and edge cases